Peripheral blood stem cell mobilization for hematopoietic support of radioimmunotherapy in patients with breast carcinoma
β Scribed by Carol M. Richman; Tina C. Schuermann; Theodore Wun; Rajiv Malik; Robert T. O'Donnell; Gerald L. DeNardo; Sally J. DeNardo
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 109 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
BACKGROUND. In clinical trials of radiolabeled monoclonal antibodies targeting
π SIMILAR VOLUMES
This study was undertaken to evaluate the relationship between the time to recovery of peripheral blood counts and CD34+ cells in the peripheral blood (PB) and apheresis collections of patients undergoing intensive chemotherapy followed by rhG-CSF. Twenty-three patients with a median age of 42 years
## BACKGROUND. In this study, the authors reviewed long term results and prognostic factors of high dose chemotherapy (HDC) with autologous stem cell support administered to 105 patients with epithelial ovarian carcinoma. ## METHODS. Prior to HDC, platinum-based chemotherapy was given to optimi
Immunocytochemical detection (ICC) of isolated tumor cells in bone marrow (BM) is currently the most established method for monitoring early dissemination in epithelial cancer. However, the low sample size that can practically be analyzed restricts the sensitivity and reliability of the ICC method.